Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Strauss

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Biochimie|July 6, 2022
Reporter system controlled by the involucrin promoter as a tool to follow epidermal differentiationMyrian Thiago Pruschinski Fernandes, Jeniffer Farias Dos Santos, Bruna Letícia Freitas, et al.
Aging|September 16, 2021
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cellsTharcisio Citrangulo Tortelli, Rodrigo Esaki Tamura, Mara de Souza Junqueira, et al.
Oncotarget|February 1, 2018
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myelomaAngela Isabel Pereira Eugênio, Veruska Lia Fook-Alves, Mariana Bleker de Oliveira, et al.
Annals of the Rheumatic Diseases|July 6, 2021
14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritisWenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, et al.
Animals : an Open Access Journal From MDPI|March 21, 2020
Humanity's Best Friend: A Dog-Centric Approach to Addressing Global ChallengesNaomi Sykes, Piers Beirne, Alexandra Horowitz, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patientsAdriana Taveira da Cruz, Aline Hunger, Fabiana Henriques Machado de Melo, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Biochimie|July 6, 2022
Reporter system controlled by the involucrin promoter as a tool to follow epidermal differentiationMyrian Thiago Pruschinski Fernandes, Jeniffer Farias Dos Santos, Bruna Letícia Freitas, et al.
Aging|September 16, 2021
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cellsTharcisio Citrangulo Tortelli, Rodrigo Esaki Tamura, Mara de Souza Junqueira, et al.
Oncotarget|February 1, 2018
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myelomaAngela Isabel Pereira Eugênio, Veruska Lia Fook-Alves, Mariana Bleker de Oliveira, et al.
Annals of the Rheumatic Diseases|July 6, 2021
14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritisWenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, et al.
Animals : an Open Access Journal From MDPI|March 21, 2020
Humanity's Best Friend: A Dog-Centric Approach to Addressing Global ChallengesNaomi Sykes, Piers Beirne, Alexandra Horowitz, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patientsAdriana Taveira da Cruz, Aline Hunger, Fabiana Henriques Machado de Melo, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
Pageof 6